Leukemia Clinical Trials in Maryland

Showing 1201-1220 of 1,651 trials

Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome

NCT01203358

The purpose of this study is to compare the efficacy of two surfactants, Exosurf Neonatal (Burroughs Wellcome Co.) and Survanta (Ross Laboratories), for the treatment of neonatal respiratory distress syndrome.

Infant, NewbornInfant, Low Birth WeightInfant, Small for Gestational Age+2 more

NICHD Neonatal Research Network617 participantsStarted Jan 1991

Palo Alto, California, United States • New Haven, Connecticut, United States • Washington D.C., District of Columbia, United States +10 more locations

COMPLETEDPhase 317 miles

Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage

NCT00009620

This large randomized trial tested whether phenobarbital given to a pregnant woman about to deliver a premature infant would prevent brain injuries in their newborns. Women with 24 to 32 week fetuses who were in preterm labor and were expected to deliver within 24 hrs were randomized to phenobarbital or usual care. They were treated until they deliver or the fetus reaches 33 wks gestation. Babies were followed until discharge and evaluated at 18-22 mos corrected age for neurodevelopmental outcome.

Infant, NewbornInfant, Low Birth WeightInfant, Small for Gestational Age+2 more

NICHD Neonatal Research Network610 participantsStarted Feb 1993

Palo Alto, California, United States • New Haven, Connecticut, United States • Washington D.C., District of Columbia, United States +8 more locations

Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome

Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage

Leukemia Trials in Other Cities

Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study

Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)

Azacitidine and Entinostat in Treating Patients With Stage I Non-Small Cell Lung Cancer That Has Been Removed By Surgery

Red Cell Transfusion Goals in Patients With Acute Leukemias

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Efficacy and Safety of Momelotinib Combined With Trametinib in Adults With Metastatic KRAS-mutated Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Platinum-Based Chemotherapy Preceded by a Dose-finding Lead-in Phase

Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy

Safety and Dose Ranging Study of Samalizumab to Treat Relapsing or Refractory CLL or MM

Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation

GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)

Immunogenicity of PCV-7 Vaccine in VLBW Infants

Early Diagnosis of Candidiasis in Premature Infants

Observational Study of Surgical Treatment of Necrotizing Enterocolotis

Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder

Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML)

LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer

Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia

Other Conditions in Maryland